Low density lipoprotein (LDL), atherosclerosis and antioxidants

被引:0
|
作者
Ryu B.H. [1 ]
机构
[1] Department of Food Science and Biotechnology, Kyungsung University
关键词
Antioxidant; Atherosclerosis; Low density lipoprotein (LDL);
D O I
10.1007/BF02942205
中图分类号
学科分类号
摘要
A crucial and causative role in the pathogenesis of atherosclerosis is believed to be the oxidative modification of low density lipoprotein (LDL). The oxidation of LDL involves released free radical driven lipid peroxidation. Several lines of evidence support the role of oxidized LDL in atherogenesis. Epidemiologic studies have demonstrated an association between an increased intake of dietary antioxidant vitamins, such as vitamin E and vitamin C and reduced morbidity and mortality from coronary artery diseases. It is thus hypothesized that dietary antioxidants may help prevent the development and progression of atherosclerosis. The oxidation of LDL has been shown to be reduced by antioxidants, and, in animal models, improved antioxidants may offer possibilities for the prevention of atherosclerosis. The results of several on going long randomized intervention trials will provide valuable information on the efficacy and safety of improved antioxidants in the prevention of atherosclerosis. This review a evaluates current literature involving antioxidants and vascular disease, with a particular focus on the potential mechanisms.
引用
收藏
页码:313 / 319
页数:6
相关论文
共 50 条
  • [11] Oxidized low density lipoprotein (Ox-LDL) as a marker of atherosclerosis in hemodialysis (HD) patients
    Takenaka, T
    Takahashi, K
    Kobayashi, T
    Oshima, E
    Iwasaki, S
    Suzuki, H
    CLINICAL NEPHROLOGY, 2002, 58 (01) : 33 - 37
  • [12] A new low density lipoprotein (LDL) adsorbent
    Yu, YH
    He, BL
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1997, 25 (05): : 445 - 450
  • [13] Nanornatertials as low density lipoprotein (LDL) sensors
    Tang, T
    Liu, XL
    Li, C
    Lei, B
    Zhang, DH
    Rouhanizadeh, M
    Hsiai, T
    Zhou, CW
    Semiconductor Materials for Sensing, 2005, 828 : 283 - 288
  • [14] PLASMA LOW DENSITY LIPOPROTEIN (LDL) - A REMNANT OF VERY LOW DENSITY LIPOPROTEIN (VLDL) CATABOLISM
    LANGER, T
    BILHEIME.D
    LEVY, RI
    CIRCULATION, 1970, 42 (04) : III7 - &
  • [15] Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL- autoantibodies in experimental atherosclerosis
    Teixeira Damasceno, Nagila Raquel
    Apolinario, Elaine
    Flauzino, Fabiana Dias
    Fernandes, Irene
    Parra Abdalla, Dulcineia Saes
    EUROPEAN JOURNAL OF NUTRITION, 2007, 46 (03) : 125 - 132
  • [16] Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia
    Toyota, Y
    Yamamura, T
    Miyake, Y
    Yamamoto, A
    ATHEROSCLEROSIS, 1999, 147 (01) : 77 - 86
  • [17] ALTERED PROPERTIES OF PLASMA LOW-DENSITY LIPOPROTEIN (LDL) IN ISCHEMIC STROKE PATIENTS WITH CAROTID ATHEROSCLEROSIS
    Puig, N.
    Camps-Renom, P.
    Aguilera-Simon, A.
    Camacho, M.
    Jimenez-Altayo, F.
    Sanchez-Quesada, J. L.
    Jimenez-Xarrie, E.
    Benitez, S.
    ATHEROSCLEROSIS, 2021, 331 : E140 - E141
  • [18] Apolipoprotein(a) [apo(a)] and low density lipoprotein receptor [LDL-R],the links between atherosclerosis and angiogenesis
    Trieu, VN
    Uckun, FM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 808 - 808
  • [19] A novel immunoglobulin G autoantibody against a cryptic epitope in low density lipoprotein (LDL) revealed in atherosclerosis
    Khamis, R.
    Woollard, K.
    Kojima, C.
    Boyle, J.
    Shah, P.
    Chang, S. -H.
    Hyde, G.
    Johns, M.
    Haskard, D.
    IMMUNOLOGY, 2014, 143 : 43 - 43
  • [20] Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis
    Wada, Y
    Kuroda, T
    Murasawa, A
    Tanabe, N
    Nakano, M
    Gejyo, E
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 482 - 486